BRAIN Biotech AG (ETR:BNN)
2.260
+0.020 (0.89%)
Sep 15, 2025, 5:36 PM CET
BRAIN Biotech AG Revenue
BRAIN Biotech AG had revenue of 13.56M EUR in the quarter ending June 30, 2025, with 0.70% growth. This brings the company's revenue in the last twelve months to 53.61M, down -4.71% year-over-year. In the fiscal year ending September 30, 2024, BRAIN Biotech AG had annual revenue of 55.50M, down -1.29%.
Revenue (ttm)
53.61M
Revenue Growth
-4.71%
P/S Ratio
0.92
Revenue / Employee
178.70K
Employees
318
Market Cap
49.38M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 55.50M | -726.00K | -1.29% |
Sep 30, 2023 | 56.23M | 5.93M | 11.79% |
Sep 30, 2022 | 50.30M | 11.07M | 28.23% |
Sep 30, 2021 | 39.22M | 158.00K | 0.40% |
Sep 30, 2020 | 39.06M | -982.00K | -2.45% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BASF SE | 64.77B |
Heidelberg Materials AG | 21.65B |
Symrise AG | 4.99B |
Covestro AG | 13.84B |
Evonik Industries AG | 14.71B |
Brenntag SE | 16.00B |
Wacker Chemie AG | 5.66B |
KWS SAAT SE & Co. KGaA | 1.66B |